IA-Body Composition CT at T12 in Idiopathic Pulmonary Fibrosis: Diagnosing Sarcopenia and Correlating with Other Morphofunctional Assessment Techniques.
Rocío Fernández-JiménezAlicia Sanmartín-SánchezEva Cabrera-CésarFrancisco Espíldora-HernándezIsabel Vegas-AguilarMaría Del Mar Amaya-CamposFiorella Ximena Palmas-CandiaMaría Claro-BrandnerJosefina Olivares-AlcoleaVíctor José Simón-FrapolliIsabel M Cornejo-ParejaPatricia Guirado-PeláezÁlvaro Vidal-SuárezAna Sánchez-GarcíaMora MurriLourdes Garrido-SánchezFrancisco J TinahonesJose Luis Velasco-GarridoJose Manuel García-AlmeidaPublished in: Nutrients (2024)
T12-CT scan is a reliable technique for measuring low muscle mass in patients with IPF, specifically when the L3 vertebrae are not captured. An SMI value of <28.8 is a good predictor of low lean mass and 12-month mortality in IPF patients.
Keyphrases
- idiopathic pulmonary fibrosis
- body composition
- computed tomography
- end stage renal disease
- dual energy
- interstitial lung disease
- image quality
- ejection fraction
- contrast enhanced
- newly diagnosed
- chronic kidney disease
- magnetic resonance imaging
- positron emission tomography
- peritoneal dialysis
- risk factors
- type diabetes
- coronary artery disease
- rheumatoid arthritis
- patient reported